Document: Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025-2025/9/25

Page: Product-specific bioequivalence guidance-2025/9/25

Document: Eltrombopag film-coated tablets 12.5 mg, 25 mg, 50 mg, 75 mg and powder for oral suspension 25 mg product-specific bioequivalence guidance-2025/9/25

Document: Melatonin prolonged release tablets 2 mg product-specific bioequivalence guidance-2025/9/25

Page: List of medicines under additional monitoring-2025/9/24

Document: Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)-2025/9/24

Document: Procedural advice on publication of information on withdrawals of marketing authorisation and variation applications for veterinary medicinal products-2025/9/24

Document: Timetable: Post-authorisation measure (PAM) assessed by PRAC-2025/9/24

Document: Timetable: Post-authorisation measure (PAM) assessed by CAT-2025/9/24

Document: Timetable: Post-authorisation measure (PAM) Paediatric art. 46 submission - ATMP-2025/9/24